According to Marksans Pharma 's latest financial reports the company's current EPS (TTM) is $0.07880. In 2022 the company made an earnings per share (EPS) of $0.06511 a decrease over its 2021 EPS that were of $0.07858.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.07880 | 21.03% |
2022 | $0.06511 | -17.15% |
2021 | $0.07858 | 18.87% |
2020 | $0.06611 | 124.41% |
2019 | $0.02946 | 39.85% |
2018 | $0.02107 | 65.56% |
2017 | $0.01272 | 279.37% |
2016 | $0.003354 | -91.46% |
2015 | $0.03928 | -2.27% |
2014 | $0.04019 | -11.5% |
2013 | $0.04541 |